PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine

BACKGROUND: Trivalent inactivated flu vaccines (TIV) are currently the best means to prevent influenza infections. However, the protection provided by TIV is partial (about 50%) and it is needed to improve the efficacy of protection. Since the respiratory tract is the main site of influenza replicat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Rioux, Gervais, Mathieu, Claudia, Russell, Alexis, Bolduc, Marilène, Laliberté-Gagné, Marie-Eve, Savard, Pierre, Leclerc, Denis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2014
Gaiak:
Short Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4022981/
https://ncbi.nlm.nih.gov/pubmed/24885884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-3155-12-19
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak